FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim.

Doctors in the UK are hoping to transform the lives of people with deadly bile duct cancer. A new study – which has shown ...

SGPGI Lucknow developed a new treatment regimen combining chemotherapy and radiotherapy for gallbladder cancer. Led by Professor Sushma Agrawal, the five-year study revealed improved life expectancy ...

CBX-12 is under clinical development by Cybrexa and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase II drugs for Gallbladder Cancer have a 32% phase transition success ...

A U.K. woman, who was diagnosed with a rare cancer, recalls having eight organs removed in what she described as 'the mother ...

Pfizer chief oncology officer Roger Dansey said: “The initial therapy of high-risk, non-muscle invasive bladder cancer with BCG has not advanced in decades. Today’s pivotal Phase III CREST ...

Bladder cancer patients given an immunotherapy drug are a third less likely to see disease come back and are more likely to survive, according to a 'game-changer' study. Patients with advanced ...

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

The SGPGI Lucknow has developed a new treatment regimen for gallbladder cancer patients, which could nearly double their life expectancy while costing a fraction of the expensive immunotherapy, ...

Research has shown that the more alcohol a person drinks, the greater the risk of cancer. Read more at straitstimes.com.

Professor Sushma Agrawal of the Radiotherapy Department at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI) led a five-year study examining the effects of altering conventional ...